Mono-Centric Retrospective Comparative Study of Sufentanil and Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section
Authors/Creators
- 1. Associate Professor, Department of Anaesthesia & Critical Care, Naraina Medical College and Research Centre, Kanpur, Uttar Pradesh
- 2. Assistant Professor, Department of Anaesthesia & Critical Care, Adesh Medical College & Hospital, Shahbad, Haryana
- 3. Associate Professor, Department of Anaesthesia & Critical Care, American International Institute of Medical Sciences (AIIMS), Udaipur, Rajasthan
Description
With a full and predictable nerve block, a quick onset, and few problems, spinal anaesthesia is a popular option for caesarean deliveries. The quality, duration, and side effects of anaesthesia are improved with the administration of various intrathecal adjuvants. This analysis of medical data involved 62 patients who had spinal anaesthesia used during caesarean deliveries. In this retrospective analysis, we evaluated 62 patients who received hyperbaric bupivacaine (0.5%, 10 mg) and dexmedetomidine (10 µg) in group 1 (n=31) and bupivacaine (0.5%, 10 mg) and sufentanil (5 µg) in group 2 (n=31). Difference in the postoperative pain, motor and sensory block, unfavourable effects within the first 24 hours after delivery, and neonatal outcomes were measured in these two groups. The sufentanil group required much less analgesia than the dexmedetomidine group. According to the VAS scale, postoperative pain in G1 was more severe than in G2. There were no obvious variations in intraoperative sensory and motor block, motor recovery times, or neonatal Apgar ratings between two groups. Shivering was only noticed in G2. The dexmedetomidine group did not experience itchiness or shivering. The sufentanil group had better postoperative analgesia, although there were more side effects overall. Dexmedetomidine used as an adjuvant stopped postoperative shaking. Contrary to what has been reported in the literature, dexmedetomidine does not produce greater or equivalent analgesia to sufentanil.
Abstract (English)
With a full and predictable nerve block, a quick onset, and few problems, spinal anaesthesia is a popular option for caesarean deliveries. The quality, duration, and side effects of anaesthesia are improved with the administration of various intrathecal adjuvants. This analysis of medical data involved 62 patients who had spinal anaesthesia used during caesarean deliveries. In this retrospective analysis, we evaluated 62 patients who received hyperbaric bupivacaine (0.5%, 10 mg) and dexmedetomidine (10 µg) in group 1 (n=31) and bupivacaine (0.5%, 10 mg) and sufentanil (5 µg) in group 2 (n=31). Difference in the postoperative pain, motor and sensory block, unfavourable effects within the first 24 hours after delivery, and neonatal outcomes were measured in these two groups. The sufentanil group required much less analgesia than the dexmedetomidine group. According to the VAS scale, postoperative pain in G1 was more severe than in G2. There were no obvious variations in intraoperative sensory and motor block, motor recovery times, or neonatal Apgar ratings between two groups. Shivering was only noticed in G2. The dexmedetomidine group did not experience itchiness or shivering. The sufentanil group had better postoperative analgesia, although there were more side effects overall. Dexmedetomidine used as an adjuvant stopped postoperative shaking. Contrary to what has been reported in the literature, dexmedetomidine does not produce greater or equivalent analgesia to sufentanil.
Files
IJPCR,Vol14,Issue12,Article31.pdf
Files
(300.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:24b16471af2021125cc1569ef1d05166
|
300.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-12-01
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue12,Article31.pdf
- Development Status
- Active
References
- 1. Liu X., Zhang X., Wang X., Wang J., Wang H. Comparative evaluation of intrathecal bupivacaine alone and bupivacaine combined with dexmedetomidine in cesarean section using spinal anesthesia: A meta-analysis. J. Int. Med. Res. 2019; 47: 2785–2799. 2. Wang Y.Q., Zhang X.J., Wang Y. Effect of intrathecal dexmedetomidine on cesarean section during spinal anesthesia: A. meta-analysis of randomized trials. Drug Des. Dev. Ther. 2019: 13: 2933– 2939. 3. Van de Velde, M. Low-dose spinal anesthesia for cesarean section to prevent spinal-induced hypotension. Curr. Opin. Anaesthesiol. 2019: 32: 268–270. 4. Sun S., Wang J., Bao, N., Chen Y., Wang J. Comparison of dexmedetomidine and fentanyl as local anesthetic adjuvants in spinal anesthesia: A systematic review and meta-analysis of randomized controlled trials. Drug Des. Dev. Ther. 2017; 11: 3413–3424. 5. Wilwerth M., Majcher J.L., Van der Linden P. Spinal fentanyl vs. sufentanil for post-operative analgesia after Csection: A double-blinded randomised trial. Acta Anaesthesiol. Scand. 2016; 60; 1306–1313. 6. Xia F., Chang X., Zhang Y., Wang L., Xiao F. The effect of intrathecal dexmedetomidine on the dose requirement of hyperbaric bupivacaine in spinal anaesthesia for caesarean section: A prospective, double-blinded, randomized study. BMC Anesthesiol. 2018; 18: 74. 7. Missant C., Teunkens A., Vandermeersch E., Van de Velde, M. Intrathecal clonidine prolongs labour analgesia but worsens fetal outcome: A pilot study. Can. J. Anaesth. 2004; 51: 696–701. 8. Dahlgren G., Hultstrand C., Jakobsson J., Norman M., Eriksson E.W., Martin H. Intrathecal sufentanil, fentanyl, or placebo added to bupivacaine for cesarean section. Anesth. Analg. 1997; 85: 1288–1293. 9. Meininger D., Byhahn C., Kessler P., Nordmeyer J., Alparslan Y., Hall B.A., Bremerich D.H. Intrathecal fentanyl, sufentanil, or placebo combined with hyperbaric mepivacaine 2% for parturient undergoing elective caesarean delivery. Anesth. Analg. 2003; 96; 852–858. 10. Hunt C.O. Spinal anesthesia for obstetrics. Int. Anesthesiol. Clin. 1989; 27: 26–30. 11. Alves B.J., Vianna, P.T.G. α2-agonistas em anestesiologia: Aspectos clínicos e farmacológicos. Rev. Bras. Anestesiol. 2000; 50: 396–404. 12. Courtnay M.A., Bader A.M., Hartwell B., Hauch M., Grennan M.J., Datta S. Perioperative analgesia with sufentanil administration. Reg. Anesth. 1992; 17: 535–540.